Midterm Exam: NR 567 / NR567 Advanced
Pharmacology for the AGACNP Exam Review |
Weeks 1- 4 Covered| Questions and Verified
Answers (2023/ 2024 Update)
1). Warfarin
Ans: Inhibits vitamin K activation of clotting factors II (prothrombin), VII, IX, and X
formed in the liver.
2). Promtamine sulfate
Ans: Heparin antidote
3). Vitamin k and fresh frozen plasma
Ans: warfarin antidote
4). Vitals, hematology, pt, inr, ptt
Ans: What assessments are to be performed on a patient using anticoagulants?
5). Ptt
Ans: normal = 20-35 seconds; on heparin therapy goal is 1.5 - 2.5 times this
6). 2-3
Ans: INR goal for warfarin therapy?
7). Pt
Ans: Normal range is 11-13.5 secs.
8). Aspirin
PaperStoc.com Page 1 of 22
, Ans: Common anti-platelet drug that can be purchased over the counter, used in
patients
9). Clopidogrel
Ans: anti-platelet used to reduce risk of stroke in patients with history of MI, CAD,
stents, bypass.
10). Ticlopidine
Ans: Anti-platelet drug reserved for patients allergic to aspirin; inhibits the binding of
fibrinogen to platelets during the first stage of the clotting cascade. Used in patients that
have already had thrombotic stroke.
11). Dipyridamole
Ans: • Inhibits cyclic nucleotide phosphodiesterase and reuptake of adenosine, both
actions result in reduced platelet aggregation and reactivity.
12). Heparin
Ans: First-line anticoagulant used for STEMI; administered with ASA, clopidogrel, and
a statin
13). Enoxaparin
Ans: may be used if the patient is not being referred for percutaneous coronary
intervention, during an MI
14). Morphine
Ans: Alleviates pain not relieved with nitrates
Produces mild vasodilation
15). Atorvastatin 80 mg loading dose, then daily.
Ans: Statin that is given during MI and the dose
16). Beta blocker
PaperStoc.com Page 2 of 22
, Ans: oral ______ ________ therapy within 24 hours of cardiac event unless
contraindicated
17). Calcium channel blockers
Ans: If beta-blockers are not tolerated, consider
18). Verapamil and dilatiazem
Ans: Examples of calcium channel blockers
19). 162-325 mg
Ans: Aspirin loading dose for an NSTEMI
20). 600 mg, 75mg daily
Ans: Loading dose of PLAVIX
21). Eptifibatide
Ans: Indicated for Acute coronary syndrome and used in combination with heparin,
aspirin, ticlid and plavix; adverse reactions: bleeding, hypotension, thrombocytopenia,
acute toxicity: decreased muscle tone, dyspnea, loss of righting reflex; baseline PT/aPTT,
H&H, platelet count ad monitor; watch for bleeding; quickly reversible so emergency
procedures may still be performed shortly after discontinuing infusion
22). Tirofiban
Ans: Glycoprotein IIb/IIIa inhibitor used for high risk patients with planned PCTA
23). Aces and arbs
Ans: Reduces cardiac remodeling post-MI, Improves patient survival in those with
heart failure or anterior myocardial infarction
24). Reteplase
PaperStoc.com Page 3 of 22
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Academik001. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $14.49. You're not tied to anything after your purchase.